Also trades as: 0570.HK (HKSE) · $vol 2M
CHIZF OTC
China Traditional Chinese Medicine Holdings Co. Limited
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -40.3%
1Y: -40.7%
3Y: -62.7%
$0.16
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$2.6B
+121.0% ▲
5Y CAGR: +10.3%
Capital Expenditures
$512M
-4.8% ▼
5Y CAGR: -15.3%
Free Cash Flow
$2.1B
+204.5% ▲
5Y CAGR: +38.1%
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$812M
+656.7% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $2.2B | $2.5B | $840M | $1.2B | $163M |
| Depreciation & Amort. | $684M | $850M | $1.1B | $1.1B | $1.1B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$2.5B | -$2.4B | -$859M | -$1.0B | $887M |
| Other Non-Cash Items | -$145M | -$223M | $12M | -$161M | $403M |
| Operating Cash Flow | $228M | $796M | $1.1B | $1.2B | $2.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.3B | -$877M | -$527M | -$484M | -$511M |
| Acquisitions (Net) | -$114M | -$23M | -$266K | -$67K | $337K |
| Investment Purchases | -$203M | -$5M | $0 | -$60M | $0 |
| Investment Sales | $73M | $203M | $5M | $60M | $0 |
| Other Investing | $421M | $165M | $148M | $6M | $132M |
| Investing Cash Flow | -$1.1B | -$537M | -$374M | -$478M | -$379M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$541M | -$182M | $111M | $67M | -$1.1B |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$216M | -$276M | -$314M | -$240M | $0 |
| Other Financing | -$258M | -$266M | -$354M | -$411M | -$254M |
| Financing Cash Flow | -$1.0B | -$724M | -$557M | -$584M | -$1.4B |
| Net Change in Cash | -$1.9B | -$468M | $162M | $107M | $812M |
| Cash End of Period | $3.2B | $2.7B | $2.9B | $3.0B | $3.8B |
| Free Cash Flow | -$1.0B | -$81M | $565M | $680M | $2.1B |